Grifols christens capacity-tripling albumin plant, pledging 200 new jobs in latest plasma push fkansteiner Wed, 10/19/2022 – 09:48 More: Grifols christens capacity-tripling albumin plant, pledging 200 new jobs in latest plasma push Source: fierce
read moreTherapy showed faster clinical recovery for combined treatment groups More: Apogenix’s asunercept demonstrates efficacy in COVID-19 trial Source: News
read moreTherapy treats refractory chronic immune thrombocytopenia and is available across UK More: Grifols’ Tavlesse receives NICE recommendation Source: News
read moreJ&J sets sights on $60B in pharma sales by 2025, targets 8 brands to deliver growth zbecker Tue, 10/18/2022 – 11:21 More: J&J sets sights on B in pharma sales by 2025, targets 8 brands to deliver growth Source: fierce
read moreRoche’s COVID drugs tumble $1B as new eye launch Vabysmo rushes to counter biosimilar-hit Lucentis aliu Tue, 10/18/2022 – 10:11 More: Roche's COVID drugs tumble B as new eye launch Vabysmo rushes to counter biosimilar-hit Lucentis Source: fierce
read moreFDA approves single-vial version of GSK’s Menveo vaccine, ending need for reconstitution ntaylor Tue, 10/18/2022 – 09:48 More: FDA approves single-vial version of GSK's Menveo vaccine, ending need for reconstitution Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals